Current research also explores how retatrutide affects glucose metabolism and energy use, which are critical for understanding its impact on metabolic health
There was a statistically significant reduction in the primary endpoint, which was a composite of cardiovascular death or worsening HF events, with an RRR of 33%
Short-acting GLP-1RAs generally lower postprandial blood glucose by delaying gastric emptying time, while long-acting GLP-1RAs reduce fasting glucagon or increase fasting insulin concentration [37]
Wegovy (semaglutide 2.4 mg) is also approved for weight management in adolescents aged 12 years and older with obesity (BMI 95th percentile for age and sex)
Cardiovascular Autonomic Neuropathy (CAN) is the most lethal form, involving oxidative damage to parasympathetic ganglia and sympathetic nerve terminals
It is responsible for inactivating incretins, such as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)